SCHEMBL22019927

SCHEMBL22019927

CC(C)n1cc(S(=N)(=O)Cl)cn1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.40
NLRP3 Q96P20 1/20 0.40
NAMPT P43490 11/20 0.36
CYP2C9 P11712 5/20 0.34
CYP2C19 P33261 2/20 0.34
CYP3A4 P08684 2/20 0.34
AURKA O14965 1/20 0.32
LIMK1 P53667 1/20 0.32
AURKB Q96GD4 1/20 0.32
KAT7 O95251 1/20 0.32
KMT2A Q03164 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
KDM5B Q9UGL1 1/20 0.31
ALDH1A1 P00352 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18007714 0.85 NLRP3 (0.44) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL22019928 0.82 ACHE (0.40) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL18029805 0.78 ACHE (0.42) ACHENLRP3NAMPTCYP2C9CYP2C19
Hydrochloric Acid SCHEMBL28184544 0.76 ACHE (0.45) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL24979079 0.72 ACHE (0.35) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL15690483 0.70 CYP2C9 (0.50) NAMPTCYP2C9CYP2C19CYP3A4KMT2A
SCHEMBL24979080 0.70 NLRP3 (0.44) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL27026402 0.68 NLRP3 (0.54) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL22531744 0.68 ACHE (0.37) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL22531742 0.68 ACHE (0.37) ACHENLRP3NAMPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed